Ligand Pharmaceuticals, Inc. (LGND)
183.13
-0.90
(-0.49%)
USD |
NASDAQ |
Dec 11, 16:00
183.40
+0.27
(+0.15%)
Pre-Market: 08:52
Ligand Pharmaceuticals Shareholders Equity (Quarterly): 950.17M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Merck & Co., Inc. | 51.85B |
| Inspire Medical Systems, Inc. | 666.46M |
| Alnylam Pharmaceuticals, Inc. | 233.89M |
| Johnson & Johnson | 79.28B |
| AbbVie, Inc. | -2.642B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.477B |
| Total Liabilities (Quarterly) | 526.60M |
| Debt to Equity Ratio | 0.4746 |
| Current Ratio | 24.69 |
| Net Debt Paydown Yield | -2.55% |